The metabolic syndrome: Setting the scene. The pros

Diabetes and Vascular Disease Research

Volumn 4, Issue SUPPL. 2, 2007, Pages

  Alberti, George ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADIPOCYTE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; PATIENT ASSESSMENT; REVIEW; SMOKING;

EID: 34547175879     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2007.017     Document Type: Review

References (14)

1. Kylin E. Studien über das Hypertonie-Hyperglykemie-Hyperurikemie syndrome. Zentralblatt für Innere Medizin 1923;7:105.
2. Marañon C. 'Prädiabetische Zustände'. Abhandlungen aus den grenzgebiete der Inneren Secretion. Wisenschafthliche Verlags Buchhandlung Rudolf Novak. 8 Co. Budapest Leipzig; 1927:12-42.
3. Vague J. La differenciation sexuelle, facteur determinant des formes de l'obesité. Presse Me 1947;53:339-40.
4. Avogaro P, Crepaldi C. Essential hyperlipidaemia, obesity and diabetes mellitus. Diabetologia 1965;1:137.
5. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
6. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, 1999.
7. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diab Med 1999;16:442-3.
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
9. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62.
10. Cenuth S, Alberti KG, Bennett P et al. the Expert Committee or the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
11. American Heart Association Scientific Statement. Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart Lung and Blood Institute Scientific Statement: executive summary. Circulation 2005;112:e285-e290.
12. Ferrannini E, Balkau B, Coppack SW et al. Insulin resistance, insulin response and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007 (epub ahead of print).
13. Dunstan DW, Zimmet P, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 1001;25:829-34.
14. Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long-term prediction of total and cardiovascular mortality: prospective, population-based cohort study. BMJ 2006;332:878-82.